Obesity-driven metabolic reprogramming and immune dysfunction in renal cancer - Poll - MDSpire

Obesity-driven metabolic reprogramming and immune dysfunction in renal cancer

By
Henry N. Ogbonna
Lyse A. Norian
June 11, 2026
0 min

Frontiers In Immunology

Share

Original Source(s)

Frontiers In Immunology

Obesity-driven metabolic reprogramming and immune dysfunction in renal cancer

by Henry N. Ogbonna, Lyse A. Norian
June 11, 2026

Related Content

Frontiers In Oncology

Subsite-specific benefit of induction chemoimmunotherapy in HPV-negative oropharyngeal squamous cell carcinoma

by Lin Zhu, Die Zhang, Jie Chen, Wei Qian, Peiyao Liu, Chunying Shen, Tingting Xu, Xin Zhou, Xueguan Lu
June 11, 2026

Frontiers In Endocrinology

Clinical outcomes of cancer patients with pre-existing autoimmune thyroid disease treated with PD-(L)-1 inhibitors: a propensity score methodology with inverse probability of treatment weighting retrospective study

by Yun Shi, Qiuyi Wang, Ziqing Ye, Doudou Chen, Tao Yang, Yongyue Wei, Xuqin Zheng
June 11, 2026

Frontiers In Surgery

Long-term results after surgical resection of intrahepatic cholangiocarcinoma before and since the BILCAP era